$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
Achmea Investment Management B.V. Decreases Stake in ResMed Inc. $RMD
03:27am, Wednesday, 18'th Mar 2026
Achmea Investment Management B.V. lowered its holdings in ResMed Inc. (NYSE: RMD) by 41.8% in the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 138
ResMed (RMD) Upgraded to Buy: Here's What You Should Know
01:01pm, Tuesday, 17'th Mar 2026
ResMed (RMD) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Is Resmed Stock the Right Pick for Your Portfolio Now?
11:55am, Tuesday, 17'th Mar 2026
RMD expands mask and device sales while maintaining strong liquidity, but macro and competitive pressures loom.
After Plunging 8.7% in 4 Weeks, Here's Why the Trend Might Reverse for ResMed (RMD)
10:35am, Tuesday, 17'th Mar 2026
The heavy selling pressure might have exhausted for ResMed (RMD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in r
Aquatic Capital Management LLC Buys 12,642 Shares of ResMed Inc. $RMD
03:25am, Monday, 16'th Mar 2026
Aquatic Capital Management LLC raised its stake in ResMed Inc. (NYSE: RMD) by 106.0% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The
3 Reasons Not to Sleep on ResMed Stock
02:30pm, Tuesday, 10'th Mar 2026
ResMed has been growing, and investing in further growth as well -- especially via digital technologies. Its stock is appealingly priced at recent levels.
ResMed Inc. (NYSE:RMD) Receives Average Recommendation of “Moderate Buy” from Analysts
02:26am, Tuesday, 10'th Mar 2026
ResMed Inc. (NYSE: RMD - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the fourteen brokerages that are presently covering the firm, MarketBeat reports. Four equities
Dundas Partners LLP Acquires 22,933 Shares of ResMed Inc. $RMD
05:08am, Monday, 09'th Mar 2026
Dundas Partners LLP increased its holdings in shares of ResMed Inc. (NYSE: RMD) by 15.1% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchan
ResMed Inc. $RMD Shares Sold by Blair William & Co. IL
04:35am, Sunday, 08'th Mar 2026
Blair William and Co. IL trimmed its position in shares of ResMed Inc. (NYSE: RMD) by 5.3% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The insti
Disney, Toast, ServiceNow And A Health Care Stock On CNBC's 'Final Trades'
07:42am, Wednesday, 04'th Mar 2026
Joshua Brown of Ritholtz Wealth Management likes Toast, and Sarat Sethi is sticking with Disney; Malcolm Ethridge chooses ServiceNow.
Elo Mutual Pension Insurance Co Raises Stock Position in ResMed Inc. $RMD
04:29am, Tuesday, 03'rd Mar 2026
Elo Mutual Pension Insurance Co raised its holdings in ResMed Inc. (NYSE: RMD) by 39.3% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The fund
Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach
03:00am, Tuesday, 03'rd Mar 2026
Insights from 30,000 people across 13 countries show global sleep health awareness is growing, yet an action gap remains 53% of people surveyed rank sleep as the most important behavior for a long,
Aster Capital Management DIFC Ltd Acquires New Shares in ResMed Inc. $RMD
03:29am, Friday, 27'th Feb 2026
Aster Capital Management DIFC Ltd purchased a new position in shares of ResMed Inc. (NYSE: RMD) during the third quarter, according to the company in its most recent disclosure with the Securities and
Empirical Asset Management LLC Purchases Shares of 3,066 ResMed Inc. $RMD
04:34am, Thursday, 26'th Feb 2026
Empirical Asset Management LLC acquired a new stake in ResMed Inc. (NYSE: RMD) in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acq
ResMed At $250: Missed Opportunity Or A Trap In The Making?
12:56pm, Wednesday, 25'th Feb 2026
ResMed (RMD) stock is currently at a fascinating juncture. It is trading at a low price, and if you decide to invest in it, you are wagering on a company that is demonstrating reasonable growth, maint
Sign In
Buy RMD